Successful use of botulinum toxin type a in the treatment of refractory postoperative dyspareunia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19622971.
- Also identified by DOI 10.1097/AOG.0b013e3181998ce1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Refractory dyspareunia presents a challenging therapeutic dilemma. A woman with defecatory dysfunction and dyspareunia presented with stage 2 prolapse. She underwent laparoscopic and vaginal pelvic floor reconstruction with excision of endometriosis. The patient experienced increased dyspareunia and de novo vaginismus postoperatively that were refractory to trigger point injections, physical therapy, and medical and surgical management. She underwent botulinum toxin type A injections into her levator ani muscles, which allowed her to have sexual intercourse again after 2 years of apareunia with no recurrence of pain for 12 months. Injecting botulinum toxin into the levator ani muscles shows promise for postoperative patients who develop vaginismus and do not respond to conservative therapy.
Medical subject headings
- Botulinum Toxins, Type A
- Dyspareunia
- Neuromuscular Agents
- Postoperative Complications
- Vaginismus